Excitotoxicity, oxidative stress, and neuronal injury

Handbook of Toxicology of Chemical Warfare Agents

Volumn , Issue , 2009, Pages 633-651

  Milatovic, Dejan ^a   Gupta, Ramesh C ^b   Zaja Milatovic, Snjezana ^a   Aschner, Michael ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MURRAY STATE UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349264701     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012374484-5.00042-0     Document Type: Chapter

References (172)

1. Andersen K.A., Diaz P.T., Wright V.P., Clanton T.L. N-tert-butyl-alpha-phenylnitrone: a free radical trap with unanticipated effects on diaphragm function. J. Appl. Physiol. 1996, 80:862-868.
2. Anderson D.E., Yuan X.J., Tseng C.M., et al. Nitrone spin traps block calcium channels and induce pulmonary artery relaxation independent of free radicals. Biochem. Biophys. Res. Commun. 1993, 193:878-885.
3. Anderson J.J., Kuo S., Chase T.N. Endogenous excitatory amino acids tonically stimulate striatal acetylcholine release through NMDA but not AMPA receptors. Neurosci. Lett. 1994, 176:264-268.
4. Behan P.D. Chronic fatigue syndrome as a delayed reaction to low dose organophosphate exposure. J. Nutr. Environ. Med 1996, 6:341-350.
5. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 1985, 14:375-403.
6. Ben-Ari Y. Cell death and synaptic reorganizations produced by seizures. Epilepsia 2001, 42:5-7.
7. Ben-Ari Y., Cossart R. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci. 2000, 23:580-587.
8. Ben-Ari Y., Ottersen O.P., Meldrum B.S. The role of epileptic activity in hippocampal and "remote' cerebral lesions induced by kainic acid. Brain Res. 1980, 191:79-97.
9. Black R.M., Clarke R.J., Read R.W., Reid M.T.J. Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to the analysis of chemical warfare samples, found to contain residues of the nerve agent sarin, sulphur mustard and their degredation products. J. Chromatogr. A 1994, 662:301-321.
10. Bolanos J.P., Peuchen S., Heales S.J., Land J.M., Clark J.B. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J. Neurochem. 1994, 63:910-916.
11. Bondy S.C., Lee D.K. Oxidative stress induced by glutamate receptor agonists. Brain Res. 1993, 610:229-233.
12. Bose R., Schnell C.P., Pinsky C., Zitko V. Effects of excitotoxin on free radical indices in mouse brain. Toxicol. Lett. 1992, 60:211-219.
13. 2{thorn} influx. Exp. Brain Res. 1989, 76:281-291.
14. Brorson J.R., Scumacker P.T., Zhang H. Nitric oxide acutely inhibits neuronal energy production. The Committees on Neurobiology and Cell Physiology. J. Neurosci. 1999, 19:147-158.
15. Burette A., Zabel U., Weinberg R.J., Schmidt H.H., ValtschanoffJ.G. Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus. J. Neurosci. 2002, 22:8961-8970.
16. Cadenas E., Davies K.J. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 2000, 29:222-230.
17. Carney J.M., Floyd R.A. Protection against oxidative damage to CNS by alpha-phenyl-tert-butylnitrone (PBN) and other spin-trapping agents: a novel series of nonlipid free radical scavengers. J. Mol. Neurosci. 1991, 3:47-57.
18. Carpentier P., Lamrinis M., Blanchet G. Early dendritic changes in hippocampal pyramidal neurons (field CA1) of rats subjected to acute soman intoxication -a light microscopic study. Brain Res. 1991, 541:293-299.
19. Cebers G., Cebere A., Wagner A., Liljequist S. Prolonged inhibition of glutamate reuptake down-regulates NMDA receptor functions in cultured cerebellar granule cells. J. Neurochem. 1999, 72:2181-2190.
20. Cebers G., Cebere A., Kovacs A.D., Hogberg H., Moreira T., Liljequist S. Increased ambient glutamate concentration alters the expression of NMDA receptor subunits in cerebellar granule neurons. Neurochem. Int. 2001, 39:151-160.
21. Cheng Y., Sun A.Y. Oxidative mechanisms involved in kainate-induced cytotoxicity in cortical neurons. Neurochem. Res. 1994, 19:1557-1564.
22. Choi W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1:623-634.
23. Chow C.K., Ibrahim W., Wei Z., Chan A.C. Vitamin E regulates mitochondrial hydrogen peroxide generation. Free Radic. Biol. Med 1999, 27:580-587.
24. Cock H.R., Tong X., Hargreaves I.P. Mitochondrial dysfunction associated with neuronal death following status epilepticus in rat. Epilepsy Res. 2002, 48:157-168.
25. Danysz W., Parsons C.G., Bresink I., Quack G. Glutamate in CNS disorders. Drug News Perspect. 1995, 8:261-277.
26. De Groot D.M., Bierman E.P., Bruijnzeel P.L., Carpentier P., Kulig B.M., Lallement G., et al. Beneficial effects of TCP on soman intoxication in guinea pigs: seizures, brain damage and learning behaviour. J. Appl. Toxicol. 2001, 21:S57-S65.
27. Deshpande S.S., Smith C.D., Filbert M.G. Assessment of primary neuronal culture as a model for soman-induced neurotoxicity and effectiveness of memantine as a neuroprotective drug. Arch. Toxicol. 1995, 69:384-390.
28. Dettbarn W.-D., Milatovic D., Zivin M., Gupta R.C. Oxidative stress, acetylcholine and excitoxicity. International Conference on Antioxidants 2001, 183-211. Prominant Press, Scottsdale, AZ. J. Marwah, A. Kanthasamy (Eds.).
29. Dettbarn W.-D., Milatovic D., Gupta R.C. Oxidative stress in anticholinesterase-induced excitoxicity. Toxicology of Organophosphate and Carbamate Compounds 2006, 511-532. Academic Press/Elsevier, Amsterdam. R.C. Gupta (Ed.).
30. Dong H., Csernansky C.A., Goico B., Csernansky J.G. Hippocampal neurogenesis following kainic acid-induced apoptosis in neonatal rats. J. Neurosci. 2003, 23:1742-1749.
31. Dudek F., Obenaus A., Schweitzer J., Wuarin J. Functional significance of hippocampal plasticity in epileptic brain: electrophysiological changes of the dentate granule cells associated with mossy fiber sprouting. Hippocampus 1994, 4:259-265.
32. Faden A.I., O'Leary D.M., Fan L., Bao W., Mullins P.G., Movsesyan V.A. Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improves outcome after brain trauma. Exp. Neurol. 2001, 167:435-444.
33. Faden I., Salzman S. Pharmacological strategies in CNS trauma. Trends Pharmacol. Sci. 1992, 13:29-35.
34. {thorn} produces progressive neuronal degeneration which is mediated by oxidative stress. Exp. Neurol. 1997, 144:193-198.
35. Fang Y.Z., Yang S., Guoyao W. Free radicals, antioxidant, and nutricion. Nutrition 2002, 18:872-879.
36. Farooqui A.A., Yi Ong W., Lu X.R., Halliwell B., Horrocks L.A. Neurochemical consequences of kainate-induced toxicity in brain: involvement of arachidonic acid release and prevention of toxicity by phospholipase A(2) inhibitors. Brain Res. Rev. 2001, 38:61-78.
37. Fessel J.P., Porter N.A., Moore K.P., Sheller J.R., Roberts L.J. Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc. Natl Acad. Sci. USA 2002, 99(26):16713-16718.
38. Fetcher L.D., Liu Y., Pearce T.A..Cochlear protection from carbon monoxide exposure by free radical blockers in the guinea pig. Toxicol. Appl. Pharmacol. 1997, 142:47-55.
39. Floyd R.A. Protective action of nitrone-based free radical traps against oxidative damage to the central nervous system. Adv. Pharmacol 1997, 38:361-378.
40. Frederiksson A., Eriksson P., Archer T. MPTP-induced deficits in motor activity: neuroprotective effects of the spin trapping agents, alpha-phenyl-tert-butylnitrone (PBN). J. Neural Trans. 1997, 104:579-592.
41. Garthwaite J., Garthwaite G., Palmer R.M.J., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. 1989, 172:413-416.
42. Gido G., Kristian T., Siesjo B.K. Extracellular potassium in a neocortical cone area after transient focal ischemia. Stroke 1997, 28:206-210.
43. Goldfrank L., Flomenbaum N., Lewin N., Weisman R., Howland M.A., Kaul B. Anticholinergic poisoning. J. Toxicol. Clin. Toxicol 1982, 19:17-25.
44. Gollnick P.D., Bertocci L.A., Kelso T.B., et al. The effect of high intensity exercise on the respiratory capacity of skeletal muscle. Pflugers Arch. Eur. J. Physiol. 1990, 415:407-413.
45. Grossman W., Jurna I. Die wirkung von memantine auf membranen sensibler nerven faserbundel. Arzneim. Forsch/Drug Res. 1997, 27:1483-1487.
46. Gunnell D., Eddleston M. Suicide by intentional ingestion of pesticides: a continuing tragedy in developing countries. Int. J. Epidemiol. 2003, 32:902-909.
47. Gupta R.C., Kadel W.L. Methyl parathion acute toxicity: prophylaxis and therapy with memantine and atropine. Arch. Int. Pharmacod. Ther. 1990, 305:208-221.
48. Gupta R.C., Dekundy A. Memantine does not influence AChE inhibition in rat brain by donepezil or rivastigmine but does with DFP and metrifonate in in vivo studies. Drug Dev. Res. 2005, 64:71-81.
49. Gupta R.C., Dettbarn W.-D. Potential of memantine, d-tubocurarine and atropine in preventing acute toxic myopathy induced by organophosphate nerve agents: soman, sarin, tabun and VX. Neurotoxicology 1992, 13:500-514.
50. Gupta R.C., Goad J.T., Milatovic D., Dettbarn W.-D. Cholinergic and noncholinergic brain biomarkers of insecticides exposure and effects. Hum. Exp. Toxicol. 2000, 19:297-308.
51. Gupta, R.C., Milatovic, D., Dettbarn, W-D. (2001a). Depletion of energy metabolites following acetylcholinesterase inhibitor-induced status epilepticus: protection by antioxidants. Neurotoxicology22: 271-82.
52. Gupta, R.C., Milatovic, D., Dettbarn, W-D. (2001b). Nitric oxide modulates high-energy phosphates in brain regions of rats intoxicated with diisopropylphosphorofluoridate or carbofuran: prevention by N-tert-butyl-a-phenylnitrone or vitamin E. Arch. Toxicol.75: 346-56.
53. Gupta, R.C., Milatovic, D., Zivin, M., Dettbarn, W-D. (2001c). Seizure-induced changes in energy metabolites and effects of N-tert-buty-a-phenylnitrone (PBN) and vitamin E. Pflugers Arch. Eur. J. Physiol.440: R160-2.
54. Gupta R.C., Milatovic S., Dettbarn W.-D., Aschner M., Milatovic D. Neuronal oxidative injury and dendritic damage induced by carbofuran: protection by memantine. Toxicol. Appl. Pharmacol. 2007, 219:97-105.
55. Gutteridge J.M., Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem. Sci. 1990, 15(4):129-135.
56. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 2007, 97:1634-1658.
57. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 2006, Oxford University Press, Oxford. 4th edn.
58. Halpain S., Hipolito A., Saffer L. Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. J. Neurosci 1998, 18:9835-9844.
59. Hatta K., Miura Y., Asukai N., Hamabe Y. Amnesia from sarin poisoning. Lancet 1996, 347:1343.
60. He Q.P., Smith M.L., Li P.A., Siesjo B.K. Necrosis of the substantia nigra, pars reticulata, influorothyl-induced status epilepticus is ameliorated by the spin trap alpha-phenyl-N-tert-butylnitrone. Free Radic. Biol. Med. 1997, 22:917-922.
61. Heinemann U., Buchheim K., Gabriel S. Cell death and metabolic activity during epileptiform discharges and status epilepticus in the hippocampus. Prog. Brain Res. 2002, 135:197-210.
62. Isokawa M., Levesque M.F. Increased NMDA responses and dendritic degeneration in human epileptic hippocampal neurons in slices. Neurosci. Lett. 1991, 132:212-216.
63. Izquierdo I., Medina J.H. Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol. Learn. Mem. 1997, 68:285-316.
64. Jamal G.A. Neurological syndromes of organophosphorous compounds. Adv. Drug React. Toxic. Rev. 1997, 16:133-170.
65. Jeffrey M., Goodsir C.M., Bruce M.E., McBride P.A., Fraser J.R. In vivo toxicity of prion protein in murine scrapie: ultrastructural and immunogold studies. Neuropathol. Appl. Neurobiol. 1997, 23:93-100.
66. Jeyarasasingam G., Yeluashvili M., Quik M. Nitric oxide is involved in acetylcholinesterase inhibitor-induced myopathy in rats. J. Pharmacol. Exp. Ther. 2000, 295:314-320.
67. Jiang M., Lee C.L., Smith K.L., Swann J.W. Spine loss and other persistent alterations of hippocampal pyramidal cell dendrites in a model of early-onset epilepsy. J. Neurosci. 1998, 18:8356-8368.
68. Johnson E.A., Daugherty K.S., Gallager S.J., Moran A.V., DeFord S.M. Glutamate receptor pathology is present in the hippocampus following repeated sub-lethal soman exposure in the absence of spatial memory deficits. Neurotoxicology. 2008, 29:73-80.
69. Koelle G.B. Pharmacology of organophosphates. J. Appl. Toxicol. 1994, 14:105-109.
70. 31P-NMR using a Langendorffperfusion technique. J. Mol. Cell Cardiol. 1993, 25:1067-1074.
71. Kreutz M.R., Bockers T.M., Bockmann J., Seidenbecher C.I., Kracht B., Vorwerk C.K., et al. Axonal injury alters alternative splicing of the retinal NR1 receptor: the preferential expression of the NR1b isoforms is crucial for retinal ganglion cell survival. J. Neurosci. 1998, 18:8278-8291.
72. 2 or as SOD mimics?. J. Biol. Chem. 1996, 271:26026-26031.
73. Kwong T.C. Organophosphate pesticides: biochemistry and clinical toxicology. Ther. Drug Monit. 2002, 24:144-149.
74. Lafon-Cazal M., Pietri S., Culcasi M., Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature 1993, 364:535-537.
75. Lallement, G., Carpenrier, P., Pernot-Marino, I., Baubichon, D., Blanchet, G. (1991a). Involvement of the different rat hippocampal glutamatergic receptors in development of seizures induced by soman: an autoradiographic study. Neurotoxicology.12: 655-64.
76. Lallement, G., Carpentier, P., Collet, A., Pernot-Marino, I., Baubichon, D., Blanchet, G. (1991b). Effects of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus. Brain Res.563: 234-40.
77. Lallement G., Denoyer M., Collet A., Pernot-Marino I., Baubichon D., Monmaur P., et al. Changes in hippocampal acetylcholine and glutamate extracellular levels during soman-induced seizures: influence of septal cholinoceptive cells. Neurosci. Lett. 1992, 139:104-107.
78. Lallement G., Shih T.M., Pernot-Marino I., Baubichon D., Foquin A., McDonough J.H. The role of nitric oxide in soman-induced seizures, neuropathology, and lethality. Pharmacol. Biochem. Behav. 1996, 54:731-737.
79. Lancelot E., Revaud M.L., Boulee R.G. Alpha-N-tert-butylnitone attenuates excitotoxicity in rat striatum by preventing hydroxyl radical accumulation. Free Radic. Biol. Med. 1997, 23:1031-1034.
80. Lemercier G., Carpentier P., Sentenac-Roumanou H., Morelis P. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol. 1983, 61:123-129.
81. Levin H.S., Rodnitzky R.L., Mick D.L. Anxiety associated with exposure to organophosphate compounds. Arch. Gen. Psychiatry 1976, 33:225-228.
82. Lipton S.A. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity uncompetitive antagonism. Curr. Alzheimer Res. 2005, 2:155-165.
83. Lizasoain I., Moro M.A., Knowles R.G., Darley-Usmar V., Moncada S. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem. J. 1996, 314:877-880.
84. Lotti M. Clinical toxicology of anticholinesterase agents in humans. Handbook of Pesticide Toxicology 2001, 1043-1085. Academic Press, San Diego. R.I. Krieger (Ed.).
85. Luthi-Carter R., Apostol B.L., Dunah A.W., DeJohn M.M., Farrell L.A., Bates G.P., et al. Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation. Neurobiol. Dis. 2003, 14:624-636.
86. Masuo K., Enomoto K.I., Maine T. Effects of memantine on the frog neuromuscular junction. Eur. J. Pharmacol. 1986, 130:187-195.
87. Mattson M.P. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromol. Med. 2003, 3:65-94.
88. McDonough J.H., Shih T.M. Pharmacological modulation of soman-induced seizures. Neurosci. Biobehav. Rev. 1993, 17:203-215.
89. McDonough J.H., Shih T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 1997, 21:559-579.
90. McLean M.J., Gupta R.C., Dettbarn W.-D., Wamil A.W. Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat. Toxicol. Appl. Pharmacol. 1992, 112:95-103.
91. McLeod G. Pathology of nerve agents: perspectives on medical management. Fundam. Appl. Toxicol. 1985, 5:S10-S16.
92. Mikuni N., Babb T.L., Christi W. Increased NR1-NR2A/B coassembly as a mechanism for rat chronic hippocampal epilepsy. Neurosci. Lett. 1999, 267:165-168.
93. Milatovic, D., Radic, Z., Zivin, M., Dettbarn, W-D. (2000a). Atypical effect of some spin trapping agents: reversible inhibition of acetylcholinesterase. Free Radic. Biol. Med.28: 597-603.
94. Milatovic, D., Zivin, M., Dettbarn, W-D. (2000b). The spin trapping agent phenyl-N-tert-butyl-nitrone (PBN) prevents excitotoxicity in skeletal muscle. Neurosci. Lett.278: 25-8.
95. Milatovic D., Zivin M., Gupta R.C., Dettbarn W.-D. Alterations in cytochrome-c-oxidase and energy metabolites in response to kainic acid-induced status epilepticus. Brain Res. 2001, 912:67-78.
96. Milatovic D., Gupta R.C., Dettbarn W.-D. Involvement of nitric oxide in kainic acid-induced excitotoxicity in rat brain. Brain Res. 2002, 957:330-337.
97. Milatovic D., Zaja-Milatovic S., Montine K.S., Horner P.J., Montine T.J. Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum. J. Neurochem. 2003, 87:1518-1526.
98. Milatovic D., Zaja-Milatovic S., Montine K., Shie F.S., Montine T.J. Neuronal oxidative damage and dendritic degeneration following activation of CD14-dependent innate immunity response in vivo. J. Neuroinflamm. 2004, 1:1-20.
99. Milatovic, D., Gupta, R.C., Dekundy, A., Montine, T.J., Dettbarn, W-D. (2005a). Carbofuran-induced oxidative stress in slow and fast skeletal muscles: prevention by memantine. Toxicology208: 13-24.
100. Milatovic, D., VanRollins, M., Li, K., Montine, K.S., Montine, T.J. (2005b). Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by alpha-or gamma-tocopherol. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.827: 88-93.
101. Milatovic D., Gupta R.C., Aschner M. Anticholinesterase toxicity and oxidative stress. The Scientific World Journal 2006, 6:295-310.
102. Mishizen-Eberz A.J., Rissman R.A., Carter T.L., Ikonomovic M.D., Wolfe B.B., Armstrong D.M. Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology. Neurobiol. Dis. 2004, 15:80-92.
103. Misulis K.E., Clinton M.E., Dettbarn W.-D., Gupta R.C. Differences in central and peripheral neural actions between soman and diisopropyl fluorophosphate, organophosphorus inhibitors of acetylcholinesterase. Toxicol. Appl. Pharmacol. 1987, 8:391-398.
104. Miyajima T., Kotake Y. Spin trap phenyl-N -tert-butylnitone (PBN) inhibits induction of nitric oxide synthase in endotoxin-induction in mice. Free Radic. Biol. Med. 1995, 22:463-470.
105. Miyajima T., Kotake Y. Spin trap phenyl N -tert-butylnitrone (PBN) for the inhibition of nitric oxide synthase induction in mice. Free Radic. Biol. Med 1997, 22:463-470.
106. Miyaki K., Nishiwaki Y., Maekawa K., Ogawa Y., Asukai N., Yoshimura K., et al. Effects of sarin on the nervous system of subway workers seven years after the Tokyo subway sarin attack. J. Occup. Health 2005, 47:299-304.
107. 2-isoprostane concentration in probable AD. Neurology 1999, 52:562-565.
108. Montine, T.J., Neely, M.D., Quinn, J.F., Beal, M.F., Markesbery, W.R., Roberts, L.J., Morrow, J.D. (2002a). Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic. Biol. Med.33(5): 620-6.
109. Montine, T.J., Quinn, L.F., Milatovic, D., Silbert, L., Dang, T., Sanchez, S., Terry, E., Roberts, L.J., Kaye, J., Morrow, J.D. (2002b). Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in patients with Alzheimer's disease or in animal model of cerebral oxidative damage. Ann. Neurol.52: 175-9.
110. Montine, T.J., Milatovic, D., Gupta, R.C., Morrow, J.D., Breyer, R. (2002c). Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent. J. Neurochem.83: 463-70.
111. Montine K.S., Quin J.F., Zhang J., Fessel J.P., Roberts L.J., Morrow J.D., Montine T.J. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem. Phys. Lipids 2004, 128:117-124.
112. Moore K., Roberts L.J. Measurement of lipid peroxidation. Free Radic. Res. 1998, 28(6):659-671.
113. Mori A., Yokoi I., Noda Y., Willmore L.J. Natural antioxidants may prevent posttraumatic epilepsy: a proposal based on experimental animal studies. Acta Med. Okayama 2004, 58:111-118.
114. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., Roberts L.J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl Acad. Sci. USA 1990, 87(23):9383-9387.
115. Morrow J.D., Roberts L.J., Daniel V.C., Awad J.A., Mirochnitchenko O., Swift L.L., Burk R.F. Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo -effects of oxygen tension and glutathione. Arch. Biochem. Biophys 1998, 353(1):160-171.
116. Muller M., Gahwiler B.H., Rietschin L., Thompson S.M. Reversible loss of dendritic spines and altered excitability after chronic epilepsy in hippocampal slice cultures. Proc. Natl Acad. Sci. USA 1993, 90:257-261.
117. Multani P., Myers R.H., Blume H.W., Schomer D.L., Sotrel A. Neocortical dendritic pathology in human partial epilepsy: a quantitative Golgi study. Epilepsia 1994, 35:728-736.
118. Nagao M., Takatori T., Matsuda Y., Nakajima M., Iwase H., Iwadate K. Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol. Appl. Pharmacol. 1997, 144:198-203.
119. Nicholls D.G., Ward M.W. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci. 2000, 23:166-174.
120. Nicholls D.G., Vesce S., Kirk L., Chalmers S. Interactions between mitochondrial bioenergetics and cytoplasmic calcium in cultured cerebellar granule cells. Cell Calcium 2003, 34:407-424.
121. Nishiwaki Y., Maekawa K., Ogawa Y., Asukai N., Minami M., Omae K. Effects of sarin on the nervous system in rescue team staffmembers and police officers 3 years after the Tokyo subway sarin attack. Environ. Health Perspect. 2001, 109:1169-1173.
122. Nozaki N., Aikawa S., Fujishima S., Suzuki M., Shinozawa Y., Hori S., Nogawa S. A case of VX poisoning and the difference from sarin. Lancet 1995, 346:698-699.
123. O'Brien R.J., Kamboj S., Ehlers M.D., Rosen K.R., Fischbach G.D., Huganir R.L. Activity-dependent modulation of synaptic AMPA receptor accumulation. Neuron 1998, 21:1067-1078.
124. O'Dell D.M., Gibson C.J., Wilson M.S., DeFord S.M., Hamm R.J. Positive and negative modulation of the GABA(A) receptor and outcome after traumatic brain injury in rats. Brain Res. 2000, 861:325-332.
125. Olney J.W., Collins R.C., Sloviter R.S. Excitotoxic mechanisms of epileptic brain damage. Adv. Neurol. 1986, 44:857-877.
126. Onodera K., Omoi N.O., Fukui K., Hayasaka T., Shinkai T., Suzuki S., Abe K., Urano S. Oxidative damage of rat cerebral cortex and hippocampus, and changes in antioxidative defense systems caused by hyperoxia. Free Radic. Res. 2003, 37:367-372.
127. Ozsuer H., Gorgulu A., Kiris T. The effect of memantine on lipid peroxidation following closed-head trauma in rats. Neurosurg. Rev. 2005, 28:143-147.
128. Parathath S., Parathath S., Tsirka S. Nitric oxide mediates neurodegeneration and breakdown of the blood brain barrier in tPA-dependent excitotoxic injury in mice. J. Cell Sci. 2006, 119:339-349.
129. Parsons C.G., Danysz W., Quack G. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist. A review of preclinical data. Neuropharmacology 1999, 38:735-767.
130. Patel M., Liang L.P., Roberts L.J. Enhanced hippocampal F2-isoprostane formation following kainate-induced seizures. J. Neurochem. 2001, 79:1065-1069.
131. Patel M.N. Oxidative stress, mitochondrial dysfunction, and epilepsy. Free Radic. Res. 2002, 36:1139-1146.
132. Pazos A.J., Green E.J., Busto R., et al. Effects of combined postischemic hypothermia and delayed N-tert-butyl-alpha-phenylnitrone (PBN) administration on histopatological and behavioral deficits associated with transient global ischemia. Brain Res. 1999, 846:186-195.
133. Phillis J.W., Clough-Helfman C. Protection from cerebral ischemic injury in gerbils with the spin trap agent N-tert-butyl-alpha-phenylnitrone (PBN). Neurosci. Lett. 1990, 116:315-319.
134. Phillips L.L., Lyeth B.G., Hamm R.J., Reeves T.M., Povlishock J.T. Glutamate antagonism during secondary deafferentiation enhances cognition and axo-dendritic integrity after traumatic brain injury. Hippocampus 1998, 8:390-401.
135. Piehl F., Tabar G., Cullheim S. Expression of NMDA receptor mRNAs in rat motoneurons is down-regulated after axotomy. Eur. J. Neurosci. 1995, 7:2101-2110.
136. Porter N.A., Caldwell S.E., Mills K.A. Mechanisms of free radical oxidation of unsaturated lipids. Lipids 1995, 30(4):277-290.
137. Punz A., Nanobashvili N., Feugl A., et al. Effect of a-tocopherol pretreatment on high energy metabolites in rabbit skeletal muscle after ischemia-reperfusion. Clin. Nutr 1998, 17:85-87.
138. Rao A., Craig A.M. Activity regulates the synaptic localization of the NMDA receptor in hippocampal neurons. Neuron 1997, 19:801-812.
139. Rauca C., Wiswedel I., Zerbe R., KeilhoffG., Krug M. The role of superoxide dismutase and alpha-tocopherol in the development of seizures and kindling induced by pentylenetetrazol -influence of the radical scavenger alpha-phenyl-N-tert-butyl nitrone. Brain Res. 2004, 1009:203-212.
140. Roberts L.J., Montine T.J., Markesbery W.R., Tapper A.R., Hardy P., Chemtob S., Dettbarn W.-D., Morrow J.D. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 1998, 273:13605-13612.
141. Sack C.A., Socci D.J., Crandall B.M., Arendash G.W. Antioxidant treatment with phenyl-alpha-tert-butylnitrone (PBN) improves the cognitive performance and survival of aging rats. Neurosci. Lett. 1996, 205:181-184.
142. Salem N., Kim H.Y., Lyergey J.A. membrane function and metabolism. Health Effects of Polyunsaturated Acids in Seafoods 1986, 263-317. Academic Press, New York, Docosahexaenoic acid. R.E. Martin (Ed.).
143. Sattler R., Charlton M.P., Hafner M., Tymianski M. Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J. Neurochem. 1998, 71:2349-2364.
144. Schwob J.E., Fuller T., Price J.L. Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neuroscience 1980, 5:991-1014.
145. Sheardown M.J., Nielsen E.O., Hansen A.J., Jacobsen P., Honore T. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science 1990, 247:571-574.
146. Shih T.M. Anticonvulsant effects of diazepam and MK-801 in soman poisoning. Epilepsy Res. 1990, 7:105-116.
147. Shih T.M., Lenz D.E., Maxwell D.M. Effects of repeated injection of sublethal doses of soman on behavior and on brain acetylcholine and choline concentrations in the rat. Psychopharmacology (Berl.) 1990, 101:489-496.
148. Simonian N.A., Coyle J.T. Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 1996, 36:83-106.
149. Sjodin B., Westing Y.H., Apple F.S. Biochemical mechanisms for oxygen free radical formation during exercise. Sports Med. 1990, 10:236-254.
150. Smith W.L. Cyclooxygenases, peroxide tone and the allure of fish oil. Curr. Opin. Cell Biol. 2005, 17:174-182.
151. Sodum R.S., Fiala E.S. Analysis of peroxynitrite reactions with guanine, xanthine, and adenine nucleosides by high-pressure liquid chromatography with electrochemical detection: C8-nitration and oxidation. Chem. Res. Toxicol. 2001, 14:438-450.
152. Soussi B., Idstrom J.P., Schersten T., Bylund-Fellenius A.C. Kinetic parameters of cytochrome c oxidase in rat skeletal muscle: effect of endurance training. Acta Physiol. Scand 1989, 135:373-379.
153. Sparenborg S., Brennecke L.H., Jaax N.K., Braitman D.J. Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman. Neuropharmacology 1992, 31:357-368.
154. Taylor P. Anticholinesterase agents. Goodman and Gilman's The Pharmacological Basis of Therapeutics 1990, 131-149. Pergamon, New York. A.G. Gilman, T.W. Rall, A.S. Nies, P. Taylor (Eds.).
155. Tayyaba K., Hasan M. Vitamin E protects against metasystox-induced adverse effect on lipid metabolism in the rat brain and spinal cord. Acta Pharmacol. Toxicol 1985, 57:190-196.
156. Thomas C.E., Ohlweiler D.F., Taylor V.L., Schmidt C.J. Radical trapping and inhibition of iron-dependent CNS damage by cyclic nitrone spin traps. J. Neurochem. 1997, 68:1173-1182.
157. Topinka J., Bincova B., Sram R.J., Erin A.N. The influence of a-tocopherol and pyritinol on oxidative DNA damage and lipid peroxidation in human lymphocytes. Mutat. Res. 1989, 225:131-136.
158. Tymianski M., Charlton M.P., Carlen P.L., Tator C.H. Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J. Neurosci. 1993, 13:2085-2104.
159. VanAcker S.A.B.E., Koymans L.M.H., Bast A. Molecular pharmacology of vitamin E: structural aspects of antioxidant activity. Free Radic. Biol. Med 1993, 15:311-328.
160. Virag L., Szabo E., Gergely P., Szabo C. Peroxynitrite-induced citotoxicity: mechanism and opportunity for intervention. Toxicol. Lett. 2003, 140-1:113-124.
161. Wade J.V., Samson F.E., Nelson S.R., Pazdernik T.L. Changes in extracellular amino acids during soman-and kainic acid-induced seizures. J. Neurochem. 1987, 49:645-650.
162. Wand P., Sontag K.H., Kremer H. Effects of 1,3-dimethyl-5-aminoadamantane hydrochloride (DMAA) on the stretch-induced reflex tension of flexor muscles and excitability of the gamma-loop in decerebrate and spinal cats. Arzneim. Forsch/Drug Res. 1977, 27:1477-1481.
163. 2 and NO on apoptosis involving activation of p38 mitogen-activated protein kinase and caspase-3. J. Neurosci. Res. 2003, 72:508-519.
164. Weinbroum A.A. Pathophysiological and clinical aspects of combat anticholinesterase poisoning. Br. Med. Bull. 2005, 72:119-133.
165. Weiss J.H., Hartley D.M., Koh J., Choi D.W. The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity. Science 1990, 247:1474-1477.
166. Wendland B., Schweize F.E., Ryan T.A., Nakane M., Murad F., Scheller R.H., Tsien R.W. Existence of nitric oxide synthase in rat hippocampal pyramidal cells. Proc. Natl Acad. Sci. USA 1994, 91:2151-2155.
167. Yang Z.P., Dettbarn W.-D. Lipid peroxidation and changes of cytochrome c oxidase and xanthine oxidase in organophosphorous anticholinesterase induced myopathy. Xth International Symposium on Cholinergic Mechanisms. J. Physiol. (Paris) 1998, 92:157-162.
168. Yuste R., Denk W. Dendritic spines as basic functional units of neuronal integration. Nature 1995, 375:682-684.
169. Zaja-Milatovic S., Gupta R.C., Aschner M., Montine T.J., Milatovic D. Pharmacologic suppression of oxidative damage and dendritic degeneration following kainic acid-induced excitotoxicity in mouse cerebrum. Neurotoxicology 2008, 29:621-627.
170. Zeng L.H., Xu L., Rensing N.R., Sinatra P.M., Rothman S.M., Wong M. Kainate seizures cause acute dendritic injury and actin depolymerization in vivo. J. Neurosci. 2007, 27:11604-11613.
171. Zhang J., Dawson V.L., Dawson T.M., Snyder S.H. Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science 1994, 263:687-689.
172. Zivin M., Milatovic D., Dettbarn W.-D. Nitrone spin trapping compound N-tert-butyl-a-phenylnitrone prevents seizure induced by anticholinesterases. Brain Res. 1999, 850:63-72.